Covered recipient · General Payments record
BRIAN THOMAS ENGEL
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$1,612.35
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $185.40 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $43.47 | 2 |
| PFIZER INC. | $33.54 | 2 |
| BioMarin Pharmaceutical Inc. | $23.35 | 1 |
| Verrica Pharmaceuticals Inc. | $21.29 | 1 |
| Cranial Technologies, Inc | $18.64 | 1 |
| Acerta Pharma LLC | $15.97 | 1 |
| Tris Pharma Inc | $15.43 | 1 |
| GlaxoSmithKline, LLC. | $13.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.97 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105737969 | CMS |
| BioMarin Pharmaceutical Inc. | $23.35 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127059971 | CMS |
| Cranial Technologies, Inc | $18.64 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082238026 | CMS |
| GlaxoSmithKline, LLC. | $13.71 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116276476 | CMS |
| Merck Sharp & Dohme LLC | $19.80 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141982541 | CMS |
| Merck Sharp & Dohme LLC | $23.67 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141977398 | CMS |
| PFIZER INC. | $19.92 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130990929 | CMS |
| PFIZER INC. | $13.62 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131769706 | CMS |
| Tris Pharma Inc | $15.43 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147213131 | CMS |
| Verrica Pharmaceuticals Inc. | $21.29 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118380058 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.